LLY news

• If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys

  Fool - Investing News · Oct 17, 2026
• Forget Zepbound: 3 Newer Drugs That Could Power Eli Lilly's Next Leg Higher

  The Motley Fool · Oct 16, 2026
• A $1,000 Investment in Eli Lilly Became $18,637. The Obesity Boom Changed Everything

  24/7 Wall Street · Oct 16, 2026
• Eli Lilly Says New Drug Drives Comprehensive Disease Control in Ulcerative Colitis Patients

  Benzinga · Oct 15, 2026
• Lilly confirms date and conference call for third-quarter 2026 financial results announcement

  PRNewsWire · Oct 15, 2026
• New composite outcomes data show patients treated with Lilly's Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn's disease at one year

  PRNewsWire · Oct 15, 2026
• Polen Focus Growth Portfolio Q3 2026 Portfolio Update

  Seeking Alpha · Oct 15, 2026
• Eli Lilly and Company $LLY Stock Sold by Fairfield Financial Advisors LTD

  Defense World · Oct 15, 2026
• Stocks Struggling With Another Bond Yield Spike

  Schaeffers Research · Oct 14, 2026
• A Look at Eli Lilly and Co (LLY) After 1.4% Decline -- GF Value $1575.10 vs Price $1166.51

  GuruFocus · Oct 13, 2026
• Here's Why Eli Lilly (LLY) Fell More Than Broader Market

  Zacks Investment Research · Oct 13, 2026
• Bristol Myers Squibb vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

  The Motley Fool · Oct 13, 2026
• Prediction: Eli Lilly Could Have More Room to Grow Than Its Valuation Suggests

  24/7 Wall Street · Oct 13, 2026
• Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff

  24/7 Wall Street · Oct 13, 2026
• Eli Lilly Reports Earnings on Oct. 29. Here's Why the Retatrutide Story Matters More Than the Quarter.

  The Motley Fool · Oct 13, 2026
• Eli Lilly and Company $LLY Stock Acquired by NorthCrest Asset Manangement LLC

  Defense World · Oct 13, 2026
• Eli Lilly and Company $LLY Stock Purchased by Woodstock Corp

  Defense World · Oct 13, 2026
• Eli Lilly Expects Up to $87 Billion in 2026 Revenue. Here's Why the Stock Still Looks Undervalued.

  The Motley Fool · Oct 13, 2026
• Will Eli Lilly Do a Stock Split Before the End of 2026?

  The Motley Fool · Oct 13, 2026
• AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

  The Motley Fool · Oct 12, 2026
• Novo Down 11% in a Month: How Should Investors Approach the Stock Now?

  Zacks Investment Research · Oct 12, 2026
• Eli Lilly and Company (NYSE:LLY) Stock Keeps “Outperform” Rating at Royal Bank Of Canada

  Defense World · Oct 12, 2026
• This Drug Combination for Eli Lilly Generated Significantly More Weight Loss Than Just Zepbound, but Discontinuation Rates Were Also Far Higher. Here's What This Could Mean for the Stock

  The Motley Fool · Oct 12, 2026
• Top 50 High-Quality Dividend Growth Stocks For October 2026

  Seeking Alpha · Oct 11, 2026
• Record Highs Beckon for Big Caps as Small Caps Lag and Deal Flow Builds

  GuruFocus · Oct 9, 2026
• Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock

  Zacks Investment Research · Oct 9, 2026
• Eli Lilly's Biggest Shareholder Just Filed to Sell $347 Million of Stock

  24/7 Wall Street · Oct 9, 2026
• Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks

  24/7 Wall Street · Oct 9, 2026
• New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesity

  PRNewsWire · Oct 9, 2026
• Eli Lilly's Obesity Business Could Become a Much Bigger Healthcare Platform

  The Motley Fool · Oct 8, 2026

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.